Enabling a new standard of care
To fight stroke and save lives
12 million
new strokes each year
since 2017, Artiria focuses on improving minimally invasive treatment of stroke
Deflectable Guidewire
Our technology represents a game-changer for neurovascular challenges when seconds matter and tortuosity hits. It provides an actively deformable tip and enhanced dynamic in-situ control re-sulting in seamless access to neurovascular targets. Our solution revisits the need for tip reshaping and defies the limits of navigation in complex vascular anatomies.
About Artiria
Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
Artiria Medical is the result of a passionate team willing to bring a new standard of care to neurointerventional surgeons for the benefit of their patients.
About us
Our playground
Latest news
- Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.
- Artiria receives FDA 510(k) clearance for Disruptive Deflectable GuidewireArtiria Medical, a Swiss neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA).
- Artiria raised CHF 3.8 M to improve stroke treatmentsArtiria Medical raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing.
Awards &
Supporters
At Artiria Medical, we are highly grateful for all the support received from our partners.
Artiria Medical has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).
